Quality Standards Resource Centre

This resource provides information on identifying and reporting adverse events related to medicines, vaccines, and medical devices. It outlines who can report, how to submit a report, the importance of these reports for safety monitoring, and the steps taken by the TGA in response to reported safety concerns. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource provides information on how to report adverse events, side effects, or problems related to medicines, vaccines, and medical devices. It includes reporting procedures and information for consumers, health professionals, and industry, aiming to enhance safety and address breaches or non-compliant advertising. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource supports health practitioners in managing medicines through the use of medication charts in aged care facilities and hospitals. It provides guidelines for safe prescribing, administration, and communication. The resource includes both paper-based and electronic medication chart systems to reduce errors, improve patient safety, and streamline medication management processes in aged care settings. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource is a training video guiding aged care staff on the importance of maintaining privacy and confidentiality for people receiving care. It covers protecting personal information, proper handling of sensitive data, and safe sharing practices, aiming to make sure clients feel secure in sharing information. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource informs older Australians about their rights and choices regarding medication, including potential side effects, the importance of informed decision-making, and reducing unnecessary antibiotic and psychotropic use. It offers brochures, videos, and fact sheets to support understanding and provide guidance on alternative treatments and safe medication practices. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards. 

This resource provides information on medication management in aged care, focusing on psychotropics and antimicrobials. It includes tools for reducing inappropriate use, antimicrobial stewardship guidance, self-assessment resources, and quality bulletins. It aims to improve medication safety, prevent inappropriate prescribing, and support care providers in ensuring safe clinical practices.

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards. 

This resource provides information on the National Aboriginal and Torres Strait Islander Flexible Aged Care Program. The program funds flexible and culturally appropriate aged care services for Aboriginal and Torres Strait Islander communities, mainly in rural and remote areas. It covers service provider requirements, funding processes, and adaptations to ongoing aged care reforms. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines essential principles to support safe and high-quality transitions of care for people across healthcare settings, including aged care. It emphasises person-centred approaches, multidisciplinary collaboration, secure record systems, and continuity of care, aiming to minimise risks during care transitions for vulnerable populations. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines the principles of safe and high-quality transitions of care. It highlights the importance of person-centred care, multidisciplinary collaboration, and clear communication between providers. It ensures coordination, accountability, and secure documentation to support continuity of care when transferring people between care settings. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This is a presentation on Polypharmacy Consumer Perspective. It includes details of a case example, resolution and care management, and key principles related to medicines and goal of care. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines the Pharmaceutical Benefits Scheme (PBS) medication chart's maximum duration in residential aged care. It explains the use of both paper-based and electronic National Residential Medication Charts (NRMC), highlighting their role in managing prescriptions, medication supply, and administration. The document provides guidance on compliance, chart expiry, and medication safety within aged care facilities. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This consensus statement outlines essential elements for recognising and responding to acute physiological deterioration in healthcare settings. It covers clinical processes like vital signs monitoring, diagnosis, and rapid response systems, as well as organisational aspects such as leadership, education, and evaluation. It provides generic information that can be applied to the aged care setting.

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines the second edition of the National Safety and Quality Health Service (NSQHS) Standards. It aims to protect people from harm and improve healthcare quality. The 8 standards cover areas like clinical governance, infection control, and medication safety, supporting aged care providers in meeting safety and quality expectations. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines the design and key components of the Support at Home program, effective from 1 November 2025. It provides guidance for aged care providers on service delivery, budgeting, and assessment processes, helping older people remain independent at home. It also details regulatory requirements and transition from existing programs. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource is a fictional scenario that follows an older person’s care pathway with a residential aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with cognitive impairment. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource is a fictional scenario that follows an older person’s care pathway with an in-home aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with dementia. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This fact sheet is informed by the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (CCS), developed by the Australian Commission on Safety and Quality in Health Care. The CCS describes the safe and appropriate use of psychotropic medicines for people with cognitive disability or impairment, in a way that upholds their rights, dignity, health and quality of life. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This framework provides a consistent national approach to clinical governance in healthcare, focusing on governance structures, leadership, culture, safety and quality improvement systems, clinical performance, care environment, and consumer partnerships. It supports healthcare organisations in developing systems to ensure accountability, safety, quality of care, and continuous improvement, following the NSQHS Standards. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource outlines clinical governance and quality improvement systems to support safe medication management. It requires health service organisations to implement systems for procuring, prescribing, dispensing, and monitoring medicines. 

This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.

This resource is chapter six of the Fourth Atlas 2021 of Healthcare Variations. The chapter examines medicines use in people aged 75 and over, focusing on polypharmacy, medication management reviews (MMRs), and proton pump inhibitor (PPI) dispensing. It highlights variations in medication use and recommends improving access to MMR services and interventions for safe, effective medication use in older populations.